Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases

Abstract

Angiogenesis is a critical step in the progression of almost all human malignancies and some other life-threatening diseases. Anti-angiogenic therapy is a novel and effective approach for treatment of angiogenesis-dependent diseases such as cancer, diabetic retinopathy, and age-related macular degeneration. In this article, we will review the main strategies developed for anti-angiogenic therapies beside their clinical applications, the major challenges, and the latest advances in the development of anti-angiogenesis-based targeted therapies.

Keywords: Angiogenesis-dependent diseases; Anti-angiogenesis; Anti-angiogenic therapeutics; Cancer; VEGF–VEGFR system receptors.